GlassScriptPhysician profile
Matthew Barra
NPI 1174082135
$10,164.75
in general payments reported to CMS, 2019-2025
7 companies · $5,949 in 2025
The $5,949 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,216 · 2025: $5,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,000 · Food and Beverage: $2,648 · Travel and Lodging: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,000.00 |
| Food and Beverage | $2,648.25 |
| Travel and Lodging | $1,516.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,514.75 | 2024-2025 | Real Intelligence, Journey, Journey II |
| Stryker Corporation | $821.24 | 2024-2025 | Mako, Restoration |
| Zimmer Biomet Holdings, INC. | $500.21 | 2024-2025 | Persona, Avenir |
| Solventum Corporation | $128.00 | 2024 | V.A.C. Veraflo, Prevena |
| Depuy Synthes Sales INC. | $77.61 | 2024 | N/A, Healix Knotless Peek, Velys |
| Medical Device Business Services, INC. | $63.94 | 2025 | Dynacord |
| Medacta USA, INC. | $59.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Barra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.